TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Brief Summary: This is a randomised, single blinded, multicentre trial to evaluate whether daily procalcitonin (PCT) measurements and immediate diagnostic and therapeutic responses to abnormal values and day-to-day changes can reduce the mortality of critically ill patients in the Intensive Care Unit (ICU).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Procalcitonin guided strategy | Intervention Type: PROCEDURE; Name: Procalcitonin guided strategy; Assigned to Arm(s): 1
B: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: No antibiotics if se-procalcitonin is below stated limit; Assigned to Arm(s): N/A
D: Arm Label: PCT guided; Type: EXPERIMENTAL; Interventions: Procedure: Earlier therapeutic changes regarding infection | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Earlier therapeutic changes regarding infection | Intervention Type: PROCEDURE; Name: Earlier therapeutic changes regarding infection; Assigned to Arm(s): Control, PCT guided

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Brief Summary: This is a randomised, single blinded, multicentre trial to evaluate whether daily procalcitonin (PCT) measurements and immediate diagnostic and therapeutic responses to abnormal values and day-to-day changes can reduce the mortality of critically ill patients in the Intensive Care Unit (ICU).


Options:
A: Arm Label: PCT guided; Type: EXPERIMENTAL; Interventions: Procedure: Earlier therapeutic changes regarding infection | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Earlier therapeutic changes regarding infection | Intervention Type: PROCEDURE; Name: Earlier therapeutic changes regarding infection; Assigned to Arm(s): Control, PCT guided
B: Arm Label: All practices; Type: OTHER; Interventions: Behavioral: DQIP Intervention | Intervention Type: BEHAVIORAL; Name: DQIP Intervention; Assigned to Arm(s): All practices
C: Arm Label: Lab-score group; Type: EXPERIMENTAL; Interventions: Biological: Allocation to the Lab-score group | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Allocation to the control group | Intervention Type: BIOLOGICAL; Name: Allocation to the Lab-score group; Assigned to Arm(s): Lab-score group | Intervention Type: BIOLOGICAL; Name: Allocation to the control group; Assigned to Arm(s): Control group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Procalcitonin guided strategy | Intervention Type: PROCEDURE; Name: Procalcitonin guided strategy; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Brief Summary: This is a randomised, single blinded, multicentre trial to evaluate whether daily procalcitonin (PCT) measurements and immediate diagnostic and therapeutic responses to abnormal values and day-to-day changes can reduce the mortality of critically ill patients in the Intensive Care Unit (ICU).


Options:
A: Arm Label: SelPCT; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite, Procedure: Procalcitonin guided therapy | Arm Label: SelKon; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite | Arm Label: PlacPCT; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Procedure: Procalcitonin guided therapy | Arm Label: PlacKon; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: sodium-selenite; Assigned to Arm(s): SelKon, SelPCT | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PlacKon, PlacPCT | Intervention Type: PROCEDURE; Name: Procalcitonin guided therapy; Assigned to Arm(s): PlacPCT, SelPCT
B: Arm Label: PCT guided; Type: EXPERIMENTAL; Interventions: Procedure: Earlier therapeutic changes regarding infection | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Earlier therapeutic changes regarding infection | Intervention Type: PROCEDURE; Name: Earlier therapeutic changes regarding infection; Assigned to Arm(s): Control, PCT guided
C: Arm Label: procalcitonin-guidance; Type: ACTIVE_COMPARATOR; Interventions: Other: procalcitonin-guidance | Arm Label: standard-of-care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: procalcitonin-guidance; Assigned to Arm(s): procalcitonin-guidance
D: Arm Label: Procalcitonin-guided group; Type: N/A; Interventions: Other: Literature search | Arm Label: Routine practice group; Type: N/A; Interventions: Other: Literature search | Intervention Type: OTHER; Name: Literature search; Assigned to Arm(s): Procalcitonin-guided group, Routine practice group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Brief Summary: This is a randomised, single blinded, multicentre trial to evaluate whether daily procalcitonin (PCT) measurements and immediate diagnostic and therapeutic responses to abnormal values and day-to-day changes can reduce the mortality of critically ill patients in the Intensive Care Unit (ICU).


Options:
A: Arm Label: PCT guided; Type: EXPERIMENTAL; Interventions: Procedure: Earlier therapeutic changes regarding infection | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Earlier therapeutic changes regarding infection | Intervention Type: PROCEDURE; Name: Earlier therapeutic changes regarding infection; Assigned to Arm(s): Control, PCT guided
B: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
C: Arm Label: Procalcitonin-guided group; Type: N/A; Interventions: Other: Literature search | Arm Label: Routine practice group; Type: N/A; Interventions: Other: Literature search | Intervention Type: OTHER; Name: Literature search; Assigned to Arm(s): Procalcitonin-guided group, Routine practice group
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Amikacin (BAY41-6551) | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: Amikacin (BAY41-6551) | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Amikacin (BAY41-6551); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Amikacin (BAY41-6551); Assigned to Arm(s): Arm 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
Brief Summary: This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.


Options:
A: Arm Label: Individual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: CenteringPregnancy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CenteringPregnancy | Arm Label: CenteringPregnancyPlus; Type: EXPERIMENTAL; Interventions: Behavioral: CenteringPregnancy, Behavioral: CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancy; Assigned to Arm(s): CenteringPregnancy, CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancyPlus; Assigned to Arm(s): CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Individual Care
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: V501 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Biological: Human Papillomavirus (HPV) 16 Monovalent | Intervention Type: BIOLOGICAL; Name: V501; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: Human Papillomavirus (HPV) 16 Monovalent; Assigned to Arm(s): 3
C: Intervention Type: BEHAVIORAL; Name: Full Parent communication intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Brief Parent Communication Intervention; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Control Parent Intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Stepping Stones | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: stepping Stones short | Intervention Type: BEHAVIORAL; Name: Stepping Stones; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: stepping Stones short; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
Brief Summary: This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ACOG education pamphlet on preeclampsia | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Preeclampsia education tool | Intervention Type: BEHAVIORAL; Name: ACOG education pamphlet on preeclampsia; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Preeclampsia education tool; Assigned to Arm(s): 3
B: Intervention Type: BEHAVIORAL; Name: Family Spirit curriculum; Assigned to Arm(s): N/A
C: Arm Label: Individual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: CenteringPregnancy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CenteringPregnancy | Arm Label: CenteringPregnancyPlus; Type: EXPERIMENTAL; Interventions: Behavioral: CenteringPregnancy, Behavioral: CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancy; Assigned to Arm(s): CenteringPregnancy, CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancyPlus; Assigned to Arm(s): CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Individual Care
D: Arm Label: Group Education; Type: EXPERIMENTAL; Interventions: Other: Group Education | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Group Education; Assigned to Arm(s): Group Education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
Brief Summary: This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.


Options:
A: Arm Label: experimental; Type: EXPERIMENTAL; Interventions: Behavioral: training | Intervention Type: BEHAVIORAL; Name: training; Assigned to Arm(s): experimental
B: Arm Label: Newhints; Type: EXPERIMENTAL; Interventions: Behavioral: Home visits | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home visits; Assigned to Arm(s): Newhints
C: Arm Label: Control Condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CHARM Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CHARM | Intervention Type: BEHAVIORAL; Name: CHARM; Assigned to Arm(s): CHARM Intervention
D: Arm Label: Individual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: CenteringPregnancy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CenteringPregnancy | Arm Label: CenteringPregnancyPlus; Type: EXPERIMENTAL; Interventions: Behavioral: CenteringPregnancy, Behavioral: CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancy; Assigned to Arm(s): CenteringPregnancy, CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancyPlus; Assigned to Arm(s): CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Individual Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
Brief Summary: This study will determine the effectiveness of two group prenatal care programs as compared to individual prenatal care in reducing the risk for HIV, STDs and adverse perinatal outcomes in young women during and after pregnancy.


Options:
A: Intervention Type: BEHAVIORAL; Name: Improved management of severe neonatal infections; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Newborn Thermal Care Practice; Assigned to Arm(s): N/A
C: Arm Label: Philani Intervention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Program | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Philani Intervention Program; Assigned to Arm(s): Philani Intervention Program
D: Arm Label: Individual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: CenteringPregnancy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CenteringPregnancy | Arm Label: CenteringPregnancyPlus; Type: EXPERIMENTAL; Interventions: Behavioral: CenteringPregnancy, Behavioral: CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancy; Assigned to Arm(s): CenteringPregnancy, CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: CenteringPregnancyPlus; Assigned to Arm(s): CenteringPregnancyPlus | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Individual Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Frequent Hemodialysis Network: Nocturnal Trial
Brief Summary: The Frequent Hemodialysis (FHN) Nocturnal Trial is a randomized controlled trial recruiting subjects from dialysis units associated with designated Clinical Centers in the U.S. and Canada and followed for 12 months. Subjects will be randomized to conventional hemodialysis delivered three days per week home arm or to the six times per week nocturnal home hemodialysis arm which will follow any dialysis prescription provided their prescribed standardized Kt/V is at least 4.0 and treatment time is at least 6.0 hours, six times per week.


Options:
A: Intervention Type: DRUG; Name: nandrolone decanoate; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: resistance exercise training; Assigned to Arm(s): N/A
B: Arm Label: N-acetylcysteine; Type: EXPERIMENTAL; Interventions: Dietary Supplement: N-acetylcysteine | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: N-acetylcysteine; Assigned to Arm(s): N-acetylcysteine | Intervention Type: DIETARY_SUPPLEMENT; Name: placebo; Assigned to Arm(s): placebo
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nocturnal home hemodialysis | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Nocturnal home hemodialysis | Intervention Type: BEHAVIORAL; Name: Nocturnal home hemodialysis; Assigned to Arm(s): 1, 2
D: Arm Label: Exercise training; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: No exercise; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual Treatment | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise training | Intervention Type: OTHER; Name: Usual Treatment; Assigned to Arm(s): No exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Frequent Hemodialysis Network: Nocturnal Trial
Brief Summary: The Frequent Hemodialysis (FHN) Nocturnal Trial is a randomized controlled trial recruiting subjects from dialysis units associated with designated Clinical Centers in the U.S. and Canada and followed for 12 months. Subjects will be randomized to conventional hemodialysis delivered three days per week home arm or to the six times per week nocturnal home hemodialysis arm which will follow any dialysis prescription provided their prescribed standardized Kt/V is at least 4.0 and treatment time is at least 6.0 hours, six times per week.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nocturnal home hemodialysis | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Nocturnal home hemodialysis | Intervention Type: BEHAVIORAL; Name: Nocturnal home hemodialysis; Assigned to Arm(s): 1, 2
B: Arm Label: Conventional hemodialysis; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional hemodialysis | Arm Label: Frequent hemodialysis; Type: EXPERIMENTAL; Interventions: Device: Frequent hemodialysis | Intervention Type: DEVICE; Name: Conventional hemodialysis; Assigned to Arm(s): Conventional hemodialysis | Intervention Type: DEVICE; Name: Frequent hemodialysis; Assigned to Arm(s): Frequent hemodialysis
C: Arm Label: Standard; Type: NO_INTERVENTION; Interventions: Device: Standard Hemodialysis | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: with Blood Volume Management (BVM®) only | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Device: with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring | Intervention Type: DEVICE; Name: Standard Hemodialysis; Assigned to Arm(s): Standard | Intervention Type: DEVICE; Name: with Blood Volume Management (BVM®) only; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring; Assigned to Arm(s): 3
D: Arm Label: Subjects undergoing sodium alignment; Type: N/A; Interventions: Other: Dialysate and serum sodium concentration aligned | Arm Label: Subjects not undergoing sodium alignment; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: Dialysate and serum sodium concentration aligned; Assigned to Arm(s): Subjects undergoing sodium alignment

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimisation of Insulin Treatment of Type 2 Diabetes Mellitus by Telecare Assistance for Self Monitoring of Blood Glucose (SMBG).
Brief Summary: * The primary objective of the present study is to verify the superiority of Telecare program vs. standard SMBG program in terms of mean HbA1c value (- 0,5%) at end-point.
* The secondary objectives of the study are the assessment of: total daily dose of insulin, changes in glycaemic and lipid profile, frequency of hypoglycaemias, changes in weight, health-related quality of life, cost-effectiveness of Telecare program vs. common ambulatory program; general safety (adverse event profile, other routine laboratory parameters).


Options:
A: Arm Label: 1; Type: OTHER; Interventions: Drug: Insulin glulisine, Drug: Insulin glargine, Drug: Metformin | Arm Label: 2; Type: OTHER; Interventions: Drug: Insulin glulisine, Drug: Insulin glargine, Drug: Metformin | Intervention Type: DRUG; Name: Insulin glulisine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Insulin glargine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 2
B: Arm Label: Geriatric Diabetes Team Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral | Arm Label: Atention Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral; Assigned to Arm(s): Geriatric Diabetes Team Intervention
C: Intervention Type: DEVICE; Name: online health information journal; Assigned to Arm(s): N/A
D: Arm Label: Active Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Financial Incentive Group I; Type: EXPERIMENTAL; Interventions: Behavioral: Financial Incentive Group I | Arm Label: Financial Incentives Group II; Type: EXPERIMENTAL; Interventions: Behavioral: Financial Incentive Group II | Intervention Type: BEHAVIORAL; Name: Financial Incentive Group I; Assigned to Arm(s): Financial Incentive Group I | Intervention Type: BEHAVIORAL; Name: Financial Incentive Group II; Assigned to Arm(s): Financial Incentives Group II

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimisation of Insulin Treatment of Type 2 Diabetes Mellitus by Telecare Assistance for Self Monitoring of Blood Glucose (SMBG).
Brief Summary: * The primary objective of the present study is to verify the superiority of Telecare program vs. standard SMBG program in terms of mean HbA1c value (- 0,5%) at end-point.
* The secondary objectives of the study are the assessment of: total daily dose of insulin, changes in glycaemic and lipid profile, frequency of hypoglycaemias, changes in weight, health-related quality of life, cost-effectiveness of Telecare program vs. common ambulatory program; general safety (adverse event profile, other routine laboratory parameters).


Options:
A: Arm Label: Videoteleconferencing AMT; Type: EXPERIMENTAL; Interventions: Behavioral: 12 sessions Anger Management Therapy. | Arm Label: Face to Face AMT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12 sessions Anger Management Therapy. | Intervention Type: BEHAVIORAL; Name: 12 sessions Anger Management Therapy.; Assigned to Arm(s): Face to Face AMT, Videoteleconferencing AMT
B: Arm Label: MSU; Type: EXPERIMENTAL; Interventions: Procedure: MSU | Arm Label: OCCM; Type: ACTIVE_COMPARATOR; Interventions: Procedure: OCCM | Intervention Type: PROCEDURE; Name: MSU; Assigned to Arm(s): MSU | Intervention Type: PROCEDURE; Name: OCCM; Assigned to Arm(s): OCCM
C: Arm Label: 1; Type: OTHER; Interventions: Drug: Insulin glulisine, Drug: Insulin glargine, Drug: Metformin | Arm Label: 2; Type: OTHER; Interventions: Drug: Insulin glulisine, Drug: Insulin glargine, Drug: Metformin | Intervention Type: DRUG; Name: Insulin glulisine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Insulin glargine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 2
D: Arm Label: Telemonitoring; Type: EXPERIMENTAL; Interventions: Procedure: Telemonitoring | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Telemonitoring; Assigned to Arm(s): Telemonitoring

Answer: C